Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study

Yu Hsi Hsieh; Hwai Jeng Lin; Jin Jian Hsieh; Kuo Chih Tseng; Chih Wei Tseng; Tsung Hsing Hung; Felix W. Leung

doi:10.1111/jgh.12183

Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study

Yu Hsi Hsieh, Hwai Jeng Lin, Jin Jian Hsieh, Kuo Chih Tseng, Chih Wei Tseng, Tsung Hsing Hung, Felix W. Leung

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Background and Aim: In Taiwan, unsedated esophagogastroduodenoscopy (EGD) is widely used, but it is uncomfortable for some patients. While meperidine has been adopted in colonoscopy, its use in EGD has not received extensive attention. This was a prospective study to investigate the use of meperidine as a single sedative agent during EGD. Methods: One hundred and forty patients were randomized to receive either 25-mg meperidine (n=70) or placebo (n=70) by intramuscular injection before EGD. The primary outcome was patient discomfort scores. The secondary outcomes included patient, endoscopist, and EGD-related variables. Results: Patients in the meperidine group reported less discomfort during esophageal intubation (median score of 2.0 and interquartile range [IQR] of 0-4.0 vs median score of 4.8 and IQR of 1.7-7.0, respectively; P

Original language	English
Pages (from-to)	1167-1173
Number of pages	7
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	28
Issue number	7
DOIs	https://doi.org/10.1111/jgh.12183
Publication status	Published - 2013

Keywords

Esophagogastroduodenoscopy
Meperidine
Minimal sedation

ASJC Scopus subject areas

Gastroenterology
Hepatology

Access to Document

10.1111/jgh.12183

Cite this

@article{e968a7028648419d97e4effc0b8efbd6,

title = "Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study",

abstract = "Background and Aim: In Taiwan, unsedated esophagogastroduodenoscopy (EGD) is widely used, but it is uncomfortable for some patients. While meperidine has been adopted in colonoscopy, its use in EGD has not received extensive attention. This was a prospective study to investigate the use of meperidine as a single sedative agent during EGD. Methods: One hundred and forty patients were randomized to receive either 25-mg meperidine (n=70) or placebo (n=70) by intramuscular injection before EGD. The primary outcome was patient discomfort scores. The secondary outcomes included patient, endoscopist, and EGD-related variables. Results: Patients in the meperidine group reported less discomfort during esophageal intubation (median score of 2.0 and interquartile range [IQR] of 0-4.0 vs median score of 4.8 and IQR of 1.7-7.0, respectively; P",

keywords = "Esophagogastroduodenoscopy, Meperidine, Minimal sedation",

author = "Hsieh, {Yu Hsi} and Lin, {Hwai Jeng} and Hsieh, {Jin Jian} and Tseng, {Kuo Chih} and Tseng, {Chih Wei} and Hung, {Tsung Hsing} and Leung, {Felix W.}",

year = "2013",

doi = "10.1111/jgh.12183",

language = "English",

volume = "28",

pages = "1167--1173",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study

AU - Hsieh, Yu Hsi

AU - Lin, Hwai Jeng

AU - Hsieh, Jin Jian

AU - Tseng, Kuo Chih

AU - Tseng, Chih Wei

AU - Hung, Tsung Hsing

AU - Leung, Felix W.

PY - 2013

Y1 - 2013

N2 - Background and Aim: In Taiwan, unsedated esophagogastroduodenoscopy (EGD) is widely used, but it is uncomfortable for some patients. While meperidine has been adopted in colonoscopy, its use in EGD has not received extensive attention. This was a prospective study to investigate the use of meperidine as a single sedative agent during EGD. Methods: One hundred and forty patients were randomized to receive either 25-mg meperidine (n=70) or placebo (n=70) by intramuscular injection before EGD. The primary outcome was patient discomfort scores. The secondary outcomes included patient, endoscopist, and EGD-related variables. Results: Patients in the meperidine group reported less discomfort during esophageal intubation (median score of 2.0 and interquartile range [IQR] of 0-4.0 vs median score of 4.8 and IQR of 1.7-7.0, respectively; P

AB - Background and Aim: In Taiwan, unsedated esophagogastroduodenoscopy (EGD) is widely used, but it is uncomfortable for some patients. While meperidine has been adopted in colonoscopy, its use in EGD has not received extensive attention. This was a prospective study to investigate the use of meperidine as a single sedative agent during EGD. Methods: One hundred and forty patients were randomized to receive either 25-mg meperidine (n=70) or placebo (n=70) by intramuscular injection before EGD. The primary outcome was patient discomfort scores. The secondary outcomes included patient, endoscopist, and EGD-related variables. Results: Patients in the meperidine group reported less discomfort during esophageal intubation (median score of 2.0 and interquartile range [IQR] of 0-4.0 vs median score of 4.8 and IQR of 1.7-7.0, respectively; P

KW - Esophagogastroduodenoscopy

KW - Meperidine

KW - Minimal sedation

UR - http://www.scopus.com/inward/record.url?scp=84879428314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879428314&partnerID=8YFLogxK

U2 - 10.1111/jgh.12183

DO - 10.1111/jgh.12183

M3 - Article

C2 - 23431993

AN - SCOPUS:84879428314

VL - 28

SP - 1167

EP - 1173

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 7

ER -

Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this